{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:49:42Z","timestamp":1791200982570,"version":"4.2.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/wnf.0b013e3182348964","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T04:18:36Z","timestamp":1321676316000},"page":"262-264","source":"Crossref","is-referenced-by-count":17,"title":["Oxcarbazepine-Responsive Paroxysmal Kinesigenic Dyskinesia in Wilson Disease"],"prefix":"10.1097","volume":"34","author":[{"given":"Federico","family":"Micheli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Tschopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Graciela","family":"Cersosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ng1293-327","article-title":". The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.","volume":"5","author":"Bull","year":"1993","journal-title":"Nat Genet"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/3.9.1647","article-title":". Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structurefunction predictions.","volume":"3","author":"Petrukhin","year":"1994","journal-title":"Hum Mol Genet"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4065\/78.9.1126","article-title":"Wilson disease.","volume":"78","author":"El-Youssef","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jnnp.2009.172213","article-title":"The paroxysmal dyskinesias.","volume":"9","author":"Van Rootselaar","year":"2009","journal-title":"Pract Neurol"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1071-9091(02)00012-8","article-title":"Paroxysmal kinesigenic dyskinesias.","volume":"10","author":"Lotze","year":"2003","journal-title":"Semin Pediatr Neurol"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1212\/01.WNL.0000147298.05983.50","article-title":". Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria.","volume":"63","author":"Bruno","year":"2004","journal-title":"Neurology"},{"key":"R8-13-20210203","first-page":"3","article-title":"Kinesigenic paroxysmal hemidyskinesia as the initial presentation of multiple sclerosis.","volume":"8","author":"Fragoso","year":"2006","journal-title":"MedGenMed"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/mds.10178","article-title":"Secondary paroxysmal dyskinesias.","volume":"17","author":"Blakeley","year":"2002","journal-title":"Mov Disord"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ana.410060514","article-title":"Paroxysmal choreoathetosis associated with thyrotoxicosis.","volume":"6","author":"Fischbeck","year":"1979","journal-title":"Ann Neurol"},{"key":"R11-13-20210203","first-page":"190","article-title":". Symptomatic paroxysmal dystonia (non-kinesigenic forms): two new cases.","volume":"14","author":"Uterga","year":"1999","journal-title":"Neurologia"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/088307389400900110","article-title":"Paroxysmal kinesigenic dystonia after methylphenidate administration.","volume":"9","author":"Gay","year":"1994","journal-title":"J Child Neurol"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/jnnp.49.8.957-a","article-title":"Focal paroxysmal kinesigenic choreoathetosis preceding the development of Steele-Richardson-Olszewski syndrome.","volume":"49","author":"Adam","year":"1986","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF02230875","article-title":"Paroxysmal dystonia due to a lesion of the cervical cord: case report.","volume":"13","author":"Previdi","year":"1992","journal-title":"Ital J Neurol Sci"},{"key":"R17-13-20210203","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1034\/j.1600-0404.2000.9l3331.x","article-title":"Oxcarbazepine therapy in paroxysmal kinesigenic choreoathetosis.","volume":"101","author":"Gokcay","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"R18-13-20210203","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/jnnp.68.6.796a","article-title":". Use of lamotrigine to treat paroxysmal kinesigenic choreoathetosis.","volume":"68","author":"Pereira","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pediatrneurol.2008.09.024","article-title":"Oxcarbazepine use in paroxysmal kinesigenic dyskinesia: report on four patients.","volume":"40","author":"Chillag","year":"2009","journal-title":"Pediatr Neurol"},{"key":"R20-13-20210203","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ncpneuro0291","article-title":"Wilsons disease: an update.","volume":"2","author":"Das","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"R21-13-20210203","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MD.0b013e318045a00e","article-title":". Wilson disease: description of 282 patients evaluated over 3 decades.","volume":"86","author":"Taly","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"R22-13-20210203","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.17.11.1121","article-title":"Seizures in Wilsons disease.","volume":"17","author":"Smith","year":"1967","journal-title":"Neurology"},{"key":"R23-13-20210203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.1987.00520160007005","article-title":". Clinical assessment of 31 patients with Wilsons disease. Correlations with structural changes on magnetic resonance imaging.","volume":"44","author":"Starosta-Rubinstein","year":"1987","journal-title":"Arch Neurol"},{"key":"R24-13-20210203","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00019052-200008000-00015","article-title":"Paroxysmal dyskinesias as a paradigm of paroxysmal movement disorders.","volume":"13","author":"Vidailhet","year":"2000","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"R27-13-20210203","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.0013-9580.2005.39904.x","article-title":"Paroxysmal dyskinesia with secondary generalization of tonic-clonic seizures in pseudohypoparathyroidism.","volume":"46","author":"Huang","year":"2005","journal-title":"Epilepsia"},{"issue":"10","key":"R28-13-20210203","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1046\/j.1528-1157.2002.13802.x","article-title":"Early-onset absence epilepsy and paroxysmal dyskinesia.","volume":"43","author":"Guerrini","year":"2002","journal-title":"Epilepsia"},{"key":"R30-13-20210203","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","article-title":". Worsening of neurologic syndrome in patients with Wilsons disease with initial penicillamine therapy.","volume":"44","author":"Brewer","year":"1987","journal-title":"Arch Neurol"},{"issue":"5","key":"R31-13-20210203","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.1990.00530050119022","article-title":"Wilsons disease. Development of neurological disease after beginning penicillamine therapy.","volume":"47","author":"Glass","year":"1990","journal-title":"Arch Neurol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201111000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:23:37Z","timestamp":1786047817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201111000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3182348964","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}